C-EPO: ready for prime-time preconditioning?
Kennedy
James
J
Calgary Stroke Program, Department of Clinical Neurosciences, University of Calgary, Foothills Medical Centre, Calgary, Canada.
Buchan
Alastair M
AM
D000818:Animals; D002545:Brain Ischemia / Q000188:drug therapy*; D004921:Erythropoietin / Q000031:analogs & derivatives* / Q000494:pharmacology*; D006801:Humans; D019194:Ischemic Preconditioning / Q000379:methods*; D018696:Neuroprotective Agents / Q000494:pharmacology*
D018696:Neuroprotective Agents; C488171:carbamylated erythropoietin; D004921:Erythropoietin